Literature DB >> 15642199

[Chromosomal imbalance in primary lung squamous cell carcinoma and their relationship with smoking].

Wen-Sheng Yan1, Lan-Ying Song, Wei-Dong Wei, Ang Li, Qi-Wan Liang, Ji-Hong Liu, Yan Fang.   

Abstract

BACKGROUND &
OBJECTIVE: Chromosomal imbalance plays an important role in tumorigenesis of lung cancer, and may be influenced by different carcinogens. This study was to examine chromosomal imbalance in primary lung squamous cell carcinoma (LSCC), and their association with smoking.
METHODS: Chromosomal gains and losses in 39 specimens of LSCC were identified by comparative genomic hybridization (CGH), the association between chromosomal imbalances in LSCC and smoking was analyzed.
RESULTS: The most frequent chromosomal gains of LSCC were detected on chromosomal arms 3q (74.4%, 29/39), 5p (66.7%, 26/39), 1q (43.6%, 17/39), 8q (41.0%, 16/39), 12p (42.6%, 18/39), 2p (38.5%, 15/39), and 18p (33.3%, 13/39), with minimal amplified regions (MAR) at 3q26.2-29 (74.4%, 29/39), 5p14.3-15.3 (66.7%, 26/39), 1q41-44(41.0%, 16/39), 8q23 (41.0%, 16/39), 12p13 (41.0%, 16/39), and 18p11.2 (33.3%, 13/39)u high-copy-number amplification at chromosomal arms 3q, and 5p were found in 15 (38.5%), and 6 (15.4%) patients. Chromosomal losses mainly involved chromosomal arms 3p (56.4%, 22/39), 5q (53.8%, 21/39), 13q (51.3%, 20/39), 8p (46.1%, 18/39), 4p (43.6%, 17/39), 4q (43.6%, 17/39), 1p (41.0%, 16/39), 2q (38.5%, 15/39), 9q (35.9%, 14/39), 13p (35.9%, 14/39), 16p (35.9%, 14/39) ,6p (33.3%, 13/39), and 6q (30.7%, 12/39), with minimal deleted regions (MDR) at 3p14.2-21.2 (51.3%, 20/39), 5q15-22 (51.3%, 20/39), 13q14.2-21.2 (48.7%, 19/39), 8p21.1-22 (43.6%, 17/39), 2q32 (35.9%, 14/39), and 16p12-13.1 (33.3%, 13/39). Amplification rates of chromosomal arms 3q, and 8q in smoking LSCC patients were significantly higher than those in non-smoking LSCC patients (P=0.002,P=0.031). While high incidences of gains at chromosomal arms 5p and 12p, and of losses at chromosomal arms 3p, 4q, and 5q were the common feature of chromosomal changes of smoking and non-smoking LSCC patients.
CONCLUSION: 3q, 5p, 1q, 8q, 12p, 2p, 18p gains and 3p, 5q, 13q, 8p, 4p, 4q, 1p, 2q, 9q, 13p,16p, 6p, 6q loses might be involved in tumorigenesis and/or progression of LSCC, smoking-induced lung cancer may be associated with 3q, 8q gains.

Entities:  

Mesh:

Year:  2005        PMID: 15642199

Source DB:  PubMed          Journal:  Ai Zheng


  7 in total

1.  MYC and human telomerase gene (TERC) copy number gain in early-stage non-small cell lung cancer.

Authors:  Antonella Flacco; Vienna Ludovini; Fortunato Bianconi; Mark Ragusa; Guido Bellezza; Francesca R Tofanetti; Lorenza Pistola; Annamaria Siggillino; Jacopo Vannucci; Lucio Cagini; Angelo Sidoni; Francesco Puma; Marileila Varella-Garcia; Lucio Crinò
Journal:  Am J Clin Oncol       Date:  2015-04       Impact factor: 2.339

2.  Prognostic Impact of EGFR Amplification and Visceral Pleural Invasion in Early Stage Pulmonary Squamous Cell Carcinomas Patients after Surgical Resection of Primary Tumor.

Authors:  Luís Miguel Chinchilla-Tábora; José María Sayagués; Idalia González-Morais; Marta Rodríguez; María Dolores Ludeña
Journal:  Cancers (Basel)       Date:  2022-04-27       Impact factor: 6.575

3.  Genetic alterations in primary gastric carcinomas correlated with clinicopathological variables by array comparative genomic hybridization.

Authors:  Ji Un Kang; Jason Jongho Kang; Kye Chul Kwon; Jong Woo Park; Tae Eun Jeong; Seung Mu Noh; Sun Hoe Koo
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

4.  Low-density lipoprotein receptor-related protein 6 (LRP6) rs10845498 polymorphism is associated with a decreased risk of non-small cell lung cancer.

Authors:  Dehou Deng; Yongjun Zhang; Wenglong Bao; Xiangming Kong
Journal:  Int J Med Sci       Date:  2014-05-02       Impact factor: 3.738

5.  Genomic alterations on 8p21-p23 are the most frequent genetic events in stage I squamous cell carcinoma of the lung.

Authors:  Jiun Kang
Journal:  Exp Ther Med       Date:  2014-12-09       Impact factor: 2.447

6.  Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung.

Authors:  Ji Un Kang; Sun Hoe Koo; Kye Chul Kwon; Jong Woo Park; Jin Man Kim
Journal:  BMC Cancer       Date:  2009-07-16       Impact factor: 4.430

7.  Allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study.

Authors:  Karolina H Czarnecka; Monika Migdalska-Sęk; Adam Antczak; Dorota Pastuszak-Lewandoska; Jacek Kordiak; Ewa Nawrot; Daria Domańska; Dorota Kaleta; Paweł Górski; Ewa Barbara Brzeziańska
Journal:  Mol Biol Rep       Date:  2013-10-04       Impact factor: 2.316

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.